Unlisted
| Company Name | 주식회사 제이투케이바이오 |
| English Name | J2KBIO Co., Ltd. |
| Business Reg. No. | 6658600626 |
| CEO | 이재섭 |
| Address | 충청북도 청주시 청원구 오창읍 두릉유리로 50-3 |
| Industry | 화장품 제조업 |
| Industry Code | 20423 |
| Main Products | 화장품원료, 의약품, 산업용 원료 |
| Established | 20161227 |
| Phone | 043-280-9000 |
| Website | www.j2kbio.com |
| Regular Employees | 54persons |
| Corp. Reg. No. | 1501110229589 |
Venture Certified
| 기술평가보증기업(기금) | 2019-01-29 ~ 2021-01-28 | 20190100653 | 2019-01-29 |
| 벤처투자유형 | 2021-01-29 ~ 2024-01-28 | 20210325010031 | 2019-01-29 |
| 혁신성장유형 | 2024-07-09 ~ 2027-07-08 | 20240709030088 | 2019-01-29 |
Revenue CAGR +43.8%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 331B | 285B | 160B |
| Operating Profit | 36B | 56B | 23B |
| Net Profit | -17B | 48B | 21B |
| Total Assets | 360B | 220B | 176B |
| Total Liabilities | 46B | 42B | 67B |
| Total Equity | 313B | 178B | 109B |
▲ 48.9%
▼ 8.6%
▼ 36.0%
▼ 65.4%
▼ 123.2%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 이재섭 | 사내이사 | 경영 총괄 | - |
| 김석종 | 사내이사 | 관리 영업 총괄 | - |
| 김대찬 | 사내이사 | 국내외 영업 총괄 | - |
| 배준태 | 미등기 | 연구 총괄 | - |
| 김영기 | 사외이사 | 사외 이사 | - |
| 하동호 | 감사 | 감사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - |
| NPS Subscribers | 62persons |
| CEO | 이재섭 |
| Est. Avg. Annual Salary | 5,06510K (42210K/mo) |
| Hired (12 mo) | +4persons |
| Left (12 mo) | -1persons |
| Net Change (12 mo) | +3persons |
| NPS Join Date | 2017-01-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "충청북도 청주시 청원구 오창읍 두릉유리로",
"brno": "665860****",
"cappedWarning": false,
"companyName": "주식회사제이투케이바이오",
"estimatedAvgAnnualSalary": 50647500,
"estimatedAvgMonthlySalary": 4220625,
"fetchedAt": "2026-03-05T11:17:21.261Z",
"industryCode": "513320",
"industryName": "화장품 및 화장용품 도매업",
"joinDate": "20170101",
"last12MonthsHired": 4,
"last12MonthsLeft": 1,
"last12MonthsNetChange": 3,
"leaveDate": null,
"monthlyPensionAmount": 24859480,
"monthlyTrend": [
{
"lostSubscribers": 1,
"newSubscribers": 4,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6774578",
"status": "1",
"styleCode": "1",
"subscriberCount": 62,
"turnoverMonths": 1
}{
"address": "충청북도 청주시",
"ceo_name": "이재섭",
"certificate": [
{
"cert_number": "20190100653",
"changes": "",
"disclosure_date": "2019-01-29",
"first_cert_date": "2019-01-29",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2019-01-29 ~ 2021-01-28"
},
{
"cert_number": "20210325010031",
"changes": "",
"disclosure_date": "2021-03-25",
"first_cert_date": "2019-01-29",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2021-01-29 ~ 2024-01-28"
},
{
"cert_number": "20240709030088",
"changes": "",
"disclosure_date": "2024-07-09",
"first_cert_date": "2019-01-29",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2024-07-09 ~ 2027-07-08"
}
],
"company_name": "주식회사 제이투케이바이오",
"corp_no": "150111-*******",
"financials": {
"2022": {
"capital_stock": 309280000,
"cost_of_sales": 8763409000,
"current_assets": 10305807000,
"current_liabilities": 3182603000,
"gross_profit": 6840886000,
"net_income": 2356719000,
"net_income_bs": 2208240000,
"non_current_assets": 7305826000,
"non_current_liabilities": 3459417000,
"non_operating_expenses": 346591000,
"non_operating_income": 376117000,
"operating_profit": 2327193000,
"revenue": 15604296000,
"sga_expenses": 4513694000,
"total_assets": 17611633000,
"total_equity": 10969613000,
"total_liabilities": 6642020000
},
"2023": {
"capital_stock": 2529920000,
"cost_of_sales": 16595172000,
"current_assets": 13510938000,
"current_liabilities": 3277252000,
"gross_profit": 11320238000,
"net_income": 5571556000,
"net_income_bs": 4797528000,
"non_current_assets": 8128982000,
"non_current_liabilities": 509355000,
"non_operating_expenses": 505028000,
"non_operating_income": 177814000,
"operating_profit": 5898770000,
"revenue": 27915410000,
"sga_expenses": 5421467000,
"total_assets": 21639920000,
"total_equity": 17853314000,
"total_liabilities": 3786606000
}
},
"industry": "화장품 제조업",
"investment": [
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2021-02-03"
}
],
"main_products": "화장품원료, 의약품, 산업용 원료",
"phone": "043-280-****",
"years": [
2023,
2022
]
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |